JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB41174

Anti-Nicotinic Acetylcholine Receptor beta 2/CHRNB2 antibody

4

(2 Reviews)

|

(3 Publications)

Rabbit Polyclonal Nicotinic Acetylcholine Receptor beta 2/CHRNB2 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 3 publications.

View Alternative Names

Neuronal acetylcholine receptor subunit beta-2, CHRNB2

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-Nicotinic Acetylcholine Receptor beta 2/CHRNB2 antibody (AB41174)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Nicotinic Acetylcholine Receptor beta 2/CHRNB2 antibody (AB41174)

ICC/IF image of ab41174 stained SHSY5Y cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab41174, 1/1000 dilution) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Western blot - Anti-Nicotinic Acetylcholine Receptor beta 2/CHRNB2 antibody (AB41174)
  • WB

Unknown

Western blot - Anti-Nicotinic Acetylcholine Receptor beta 2/CHRNB2 antibody (AB41174)

The band observed at 52 kDa could potentially be a cleaved form of Nicotinic Acetylcholine Receptor beta 2/CHRNB2 due to the presence of a 25 amino acid signal peptide.

All lanes:

Western blot - Anti-Nicotinic Acetylcholine Receptor beta 2/CHRNB2 antibody (ab41174) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 57 kDa

Observed band size: 46 kDa,52 kDa

true

Exposure time: 3min

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/400", "WB-species-notes": "<p>With this antibody, we have found that blocking with 5% goat or donkey serum significantly reduces background as compared to BSA or milk.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/200", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Lyophilized
Reconstitution
reconstitute with PBS, 10 mg/mL BSA at 0.1mL
Purity
Whole antiserum
Storage buffer
Constituents: Whole serum, PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Nicotinic Acetylcholine Receptor beta 2 (CHRNB2) also known as nAChR beta-2 subunit is an integral membrane protein involved in forming ligand-gated ion channels. It has a pivotal role in neurotransmission by responding to the neurotransmitter acetylcholine. CHRNB2 typically forms heteromeric complexes with alpha subunits to yield functional receptors. It is highly expressed in the central nervous system including regions such as the cerebral cortex and hippocampus. Each beta-2 subunit has a molecular mass of approximately 50 kDa.
Biological function summary

CHRNB2 influences synaptic plasticity and cognitive processes. It functions as part of a pentameric receptor complex usually composed of various subunits that determine the receptor's physiological properties. The receptor modulates neurotransmitter release and impacts neuronal excitability. Its activity contributes to cognitive functions such as attention learning and memory mediated through ion flow across cell membranes that affect neuron firing rates.

Pathways

The beta-2 subunit of the nicotinic acetylcholine receptor is integral to the cholinergic pathway. It interacts with the dopaminergic system by modulating dopaminergic neuron activity and dopamine release. This interaction plays a significant role in pathways related to reward pleasure and addiction. Proteins such as the dopamine transporter (DAT) are closely linked within these pathways affecting the dynamics of neurotransmitter availability and receptor activation.

Alterations in CHRNB2 function associate with neurological disorders like nicotine addiction and Alzheimer's disease. Dysfunctional receptors due to mutations can disrupt cognitive function and behavior highlighting their role in Alzheimer's pathology where neuronal communication is impaired. Other proteins such as amyloid precursor protein (APP) link CHRNB2 to the disease process by influencing neurodegenerative outcomes and synaptic maintenance.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, cation permeability, and binding to allosteric modulators (PubMed : 22361591, PubMed : 27698419, PubMed : 29720657, PubMed : 38454578). CHRNB2 forms heteropentameric neuronal acetylcholine receptors with CHRNA2, CHRNA3, CHRNA4 and CHRNA6, as well as CHRNA5 and CHRNB3 as accesory subunits (PubMed : 16835356, PubMed : 20881005, PubMed : 22361591, PubMed : 27698419, PubMed : 29720657, PubMed : 38454578, PubMed : 8663494). Found in two major stoichiometric forms,(CHRNA4)3 : (CHRNB2)2 and (CHRNA4)2 : (CHRNB2)3, the two stoichiometric forms differ in their unitary conductance, calcium permeability, ACh sensitivity and potentiation by divalent cation (PubMed : 27698419, PubMed : 29720657, PubMed : 38454578). Heteropentameric channels with CHRNA6 and CHRNA4 exhibit high sensitivity to ACh and nicotine and are predominantly expressed in only a few brain areas, including dopaminergic neurons, norepirephrine neurons and cells of the visual system. nAChrs containing CHRNA6 subunits mediate endogenous cholinergic modulation of dopamine and gamma-aminobutyric acid (GABA) release in response to nicotine at nerve terminals (By similarity). Also forms functional nAChRs with other subunits such as CHRNA7 : CHRNB2, mainly expressed in basal forebrain cholinergic neurons (PubMed : 33239400, PubMed : 38161283).
See full target information CHRNB2

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:5925 PubMed40593693

2025

α7 nicotinic acetylcholine receptors regulate radial glia fate in the developing human cortex.

Applications

Unspecified application

Species

Unspecified reactive species

Tanzila Mukhtar,Clara-Vita Siebert,Yuejun Wang,Mark-Phillip Pebworth,Matthew L White,Tianzhi Wu,Tan Ieng Huang,Guolong Zuo,Jayden Ross,Jennifer Baltazar,Varun Upadhyay,Merut Shankar,Li Zhou,Isabel Lombardi-Coronel,Ishaan Mandala,Manal A Adam,Shaohui Wang,Qiuli Bi,Marco F M Hoekman,Jingjing Li,Arnold R Kriegstein

Cancer cell international 22:340 PubMed36344976

2022

CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Cheng Qin,Tianhao Li,Yuanyang Wang,Bangbo Zhao,Zeru Li,Tianyu Li,Xiaoying Yang,Yutong Zhao,Weibin Wang

Nature communications 10:4037 PubMed31492869

2019

Central nicotine induces browning through hypothalamic κ opioid receptor.

Applications

Unspecified application

Species

Unspecified reactive species

Patricia Seoane-Collazo,Laura Liñares-Pose,Eva Rial-Pensado,Amparo Romero-Picó,José María Moreno-Navarrete,Noelia Martínez-Sánchez,Pablo Garrido-Gil,Ramón Iglesias-Rey,Donald A Morgan,Naoki Tomasini,Samuel Andrew Malone,Ana Senra,Cintia Folgueira,Gema Medina-Gomez,Tomás Sobrino,José L Labandeira-García,Rubén Nogueiras,Ana I Domingos,José-Manuel Fernández-Real,Kamal Rahmouni,Carlos Diéguez,Miguel López
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com